1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HHLA3 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA RMI2 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA UBE2Q2L CTRPv2 pan-cancer AAC -0.088 0.01
mRNA ARHGEF12 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA KRBA1 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA ATP5L CTRPv2 pan-cancer AAC -0.089 0.01
mRNA PSKH2 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA ADAL CTRPv2 pan-cancer AAC -0.091 0.01
mRNA TDRKH CTRPv2 pan-cancer AAC -0.092 0.01
mRNA MPHOSPH9 CTRPv2 pan-cancer AAC -0.092 0.01
Download CSV